Literature DB >> 1704344

Responses of T cells from sensitized donors to recombinant and synthetic peptides corresponding to sequences of the Plasmodium falciparum SERP antigen.

C Roussilhon1, E Hundt, M Agrapart, W Stüber, B Knapp, P Dubois, J J Ballet.   

Abstract

In the present work, we intend to determine the capacity of human lymphocytes to recognize subfragments of the serine-stretch protein SERP, a blood-stage antigen from Plasmodium falciparum. Individuals sensitized by a previous P. falciparum infection were studied. Some recombinant proteins (RP) including RP7 and RP10 (amino acids 631-684 and 631-892 of SERP, respectively), were recognized in proliferation assays by lymphocytes from 28 sensitized individuals and not by lymphocytes from control, non-sensitized, donors. Synthetic peptides covering predefined zones of particular interest were tested and appeared to induce proliferative responses of lymphocytes from sensitized donors, allowing identification of putative T cell epitopes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1704344     DOI: 10.1016/0165-2478(90)90107-2

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Protection of Aotus monkeys from malaria infection by immunization with recombinant hybrid proteins.

Authors:  B Knapp; E Hundt; B Enders; H A Küpper
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  H-2b restriction of the immune response to the p126 Plasmodium falciparum antigen.

Authors:  D M Banic; P Delplace; C Mazingue; D Camus
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

3.  Immunization of Aotus monkeys with recombinant Plasmodium falciparum hybrid proteins does not reproducibly result in protection from malaria infection.

Authors:  C H Kocken; E Hundt; B Knapp; D Brazel; B Enders; D L Narum; J A Wubben; A W Thomas
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

4.  Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus.

Authors:  J A Tine; V Conseil; P Delplace; C De Taisne; D Camus; E Paoletti
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  Conservation of antigen components from two recombinant hybrid proteins protective against malaria.

Authors:  B Knapp; U Nau; E Hundt
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

6.  Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.

Authors:  B U von Specht; B Knapp; G Muth; M Bröker; K D Hungerer; K D Diehl; K Massarrat; A Seemann; H Domdey
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

7.  Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon.

Authors:  Lilian Rose Pratt-Riccio; Selma Sallenave-Sales; Joseli de Oliveira-Ferreira; Bruno T da Silva; Monick Lindenmeyer Guimarães; Fátima Santos; Thatiane S de Simone; Mariza G Morgado; Salvatore G de Simone; Maria de Fátima Ferreira-Da-Cruz; Cláudio T Daniel-Ribeiro; Mariano G Zalis; Daniel Camus; Dalma M Banic
Journal:  Malar J       Date:  2008-07-30       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.